位置:首页 > 蛋白库 > B1Q_LOXIN
B1Q_LOXIN
ID   B1Q_LOXIN               Reviewed;         305 AA.
AC   Q1W694;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 1.
DT   03-AUG-2022, entry version 58.
DE   RecName: Full=Dermonecrotic toxin LiSicTox-betaID1;
DE            EC=4.6.1.- {ECO:0000250|UniProtKB:Q4ZFU2};
DE   AltName: Full=Dermonecrotic toxin 5;
DE            Short=DT5 {ECO:0000303|PubMed:21590705};
DE   AltName: Full=LiRecDT5 {ECO:0000303|PubMed:17296256, ECO:0000303|PubMed:21590705};
DE   AltName: Full=Phospholipase D;
DE            Short=PLD;
DE   AltName: Full=Sphingomyelin phosphodiesterase D 5;
DE            Short=SMD 5;
DE            Short=SMase D 5;
DE            Short=Sphingomyelinase D 5;
DE   Flags: Precursor;
OS   Loxosceles intermedia (Brown spider).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC   Araneomorphae; Haplogynae; Scytodoidea; Sicariidae; Loxosceles.
OX   NCBI_TaxID=58218;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOASSAY, AND CATALYTIC ACTIVITY.
RC   TISSUE=Venom gland;
RX   PubMed=17296256; DOI=10.1016/j.biochi.2006.12.002;
RA   da Silveira R.B., Pigozzo R.B., Chaim O.M., Appel M.H., Silva D.T.,
RA   Dreyfuss J.L., Toma L., Dietrich C.P., Nader H.B., Veiga S.S., Gremski W.;
RT   "Two novel dermonecrotic toxins LiRecDT4 and LiRecDT5 from Brown spider
RT   (Loxosceles intermedia) venom: from cloning to functional
RT   characterization.";
RL   Biochimie 89:289-300(2007).
RN   [2]
RP   FUNCTION.
RX   PubMed=21590705; DOI=10.1002/jcb.23177;
RA   Chaves-Moreira D., Souza F.N., Fogaca R.T., Mangili O.C., Gremski W.,
RA   Senff-Ribeiro A., Chaim O.M., Veiga S.S.;
RT   "The relationship between calcium and the metabolism of plasma membrane
RT   phospholipids in hemolysis induced by brown spider venom phospholipase-D
RT   toxin.";
RL   J. Cell. Biochem. 112:2529-2540(2011).
CC   -!- FUNCTION: Dermonecrotic toxins cleave the phosphodiester linkage
CC       between the phosphate and headgroup of certain phospholipids
CC       (sphingolipid and lysolipid substrates), forming an alcohol (often
CC       choline) and a cyclic phosphate (By similarity). This toxin acts on
CC       sphingomyelin (SM) with low activity (PubMed:17296256). It may also act
CC       on ceramide phosphoethanolamine (CPE), lysophosphatidylcholine (LPC)
CC       and lysophosphatidylethanolamine (LPE), but not on
CC       lysophosphatidylserine (LPS), and lysophosphatidylglycerol (LPG) (By
CC       similarity). It acts by transphosphatidylation, releasing exclusively
CC       cyclic phosphate products as second products (By similarity). Has no or
CC       weak activities in inducing dermonecrosis, hemolysis, inflammatory
CC       response, platelet aggregation and increase in vessel permeability
CC       (PubMed:17296256, PubMed:21590705). In vivo, shows no lethality when
CC       injected at higher dose into mice (PubMed:17296256).
CC       {ECO:0000250|UniProtKB:A0A0D4WTV1, ECO:0000269|PubMed:17296256,
CC       ECO:0000269|PubMed:21590705}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphocholine = an N-(acyl)-sphingosyl-
CC         1,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60652,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:64583, ChEBI:CHEBI:143892;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphoethanolamine = an N-(acyl)-
CC         sphingosyl-1,3-cyclic phosphate + ethanolamine; Xref=Rhea:RHEA:60648,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:143891, ChEBI:CHEBI:143892;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine = a 1-acyl-sn-glycero-
CC         2,3-cyclic phosphate + choline; Xref=Rhea:RHEA:60700,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:58168, ChEBI:CHEBI:143947;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine = a 1-acyl-sn-
CC         glycero-2,3-cyclic phosphate + ethanolamine; Xref=Rhea:RHEA:60704,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:64381, ChEBI:CHEBI:143947;
CC         Evidence={ECO:0000250|UniProtKB:A0A0D4WTV1};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q8I914};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:Q8I914};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:17296256}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:17296256}.
CC   -!- SIMILARITY: Belongs to the arthropod phospholipase D family. Class II
CC       subfamily. Class IIb sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: The most common activity assay for dermonecrotic toxins
CC       detects enzymatic activity by monitoring choline release from
CC       substrate. Liberation of choline from sphingomyelin (SM) or
CC       lysophosphatidylcholine (LPC) is commonly assumed to result from
CC       substrate hydrolysis, giving either ceramide-1-phosphate (C1P) or
CC       lysophosphatidic acid (LPA), respectively, as a second product.
CC       However, two studies from Lajoie and colleagues (2013 and 2015) report
CC       the observation of exclusive formation of cyclic phosphate products as
CC       second products, resulting from intramolecular transphosphatidylation.
CC       Cyclic phosphates have vastly different biological properties from
CC       their monoester counterparts, and they may be relevant to the pathology
CC       of brown spider envenomation. {ECO:0000250|UniProtKB:A0A0D4WTV1,
CC       ECO:0000250|UniProtKB:A0A0D4WV12, ECO:0000250|UniProtKB:Q4ZFU2}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ431849; ABD91847.1; -; mRNA.
DR   AlphaFoldDB; Q1W694; -.
DR   SMR; Q1W694; -.
DR   ArachnoServer; AS000145; Sphingomyelinase D (LiSicTox-betaID1).
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004620; F:phospholipase activity; IDA:UniProtKB.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IDA:UniProtKB.
DR   GO; GO:0044398; P:envenomation resulting in induction of edema in another organism; IDA:UniProtKB.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   SUPFAM; SSF51695; SSF51695; 1.
PE   1: Evidence at protein level;
KW   Cytolysis; Dermonecrotic toxin; Disulfide bond; Hemolysis;
KW   Lipid degradation; Lipid metabolism; Lyase; Magnesium; Metal-binding;
KW   Secreted; Signal; Toxin; Zymogen.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   PROPEP          19..26
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000279569"
FT   CHAIN           27..305
FT                   /note="Dermonecrotic toxin LiSicTox-betaID1"
FT                   /id="PRO_0000279570"
FT   ACT_SITE        38
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   ACT_SITE        74
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         58
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         60
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   BINDING         118
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I914"
FT   DISULFID        78..84
FT                   /evidence="ECO:0000250|UniProtKB:P0CE80"
FT   DISULFID        80..223
FT                   /evidence="ECO:0000250|UniProtKB:P0CE80"
SQ   SEQUENCE   305 AA;  34831 MW;  64DCFF5B5B1C315D CRC64;
     MQLFIILCLA GSAVQLEGTE LDGVERADNR RPIWNIAHMV NDKGLIDEYL DDGANSVESD
     VSFDSNGKPE KMLHGSPCDC GRSCKRQMSF ADYLDYMRQL TTPGDPKFRE NLILVMLDLK
     LKKLSSEQAY SAGQEVASQM LDKYWKRGES GARAYIVLSI PTITRVTFVN GFYDKLHSEG
     FDQYREKVGV DFSGNEDLED TGKILKSRDI LDHIWQSDGI TNCLFRIMKR LKAAIRKRDS
     NGYMVKVYTW SVDKYTTMRK ALRAGADGMI TNFPKRLVSV LNEREFSGKF RLATYNDNPW
     ERYTG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024